Caglar Kuas

Caglar Kuas

Auto-generated profile, based on publicly available information

Caglar Kuas

Department of Emergency Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

15 July 2025 in The Journal of Emergency Medicine
Verified
Journal Article
Closed access
CKCaglar Kuas
Caglar Kuas
MCMustafa Emin Canakci
Mustafa Emin Canakci
NANurdan Acar
Nurdan Acar
AKAltug Kanbakan
Altug Kanbakan
MCMurat Cetin
Murat Cetin
EGErtug Gunsoy
Ertug Gunsoy

24 March 2026 in The Journal of Emergency Medicine
Verified
Journal Article
Closed access
VEVolkan Ercan
Volkan Ercan
EOEngin Ozakin
Engin Ozakin
AOAtilla Ozcan Ozdemir
Atilla Ozcan Ozdemir
ÖAözlem Aykaç
özlem Aykaç
MKMuhammed Evvah Karakilic
Muhammed Evvah Karakilic
RCRuhi Cure
Ruhi Cure

1 January 2020 in Indian Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
FKFiliz baloğlu kaya
Filiz baloğlu kaya
CKCaglar Kuas
Caglar Kuas
EOEngin Ozakin
Engin Ozakin
MKMuhammed Evvah Karakilic
Muhammed Evvah Karakilic
SKSeyhmus Kaya
Seyhmus Kaya
There are a limited number of studies on postoverdose clinical findings of mirtazapine in the literature. Our case presented an unlikely junctional rhythm, which we have not seen in the previous studies, in a patient who had bradycardia and hypotension following mirtazapine intake. A 37-year old male was admitted to the emergency department (ED) after his suicide attempt with 300 mg PO of mirtazapine tablets. He took the drug 2 h prior to his ED visit. He did not have any complaints after the mirtazapine intake. His complete physical examination and electrocardiography (ECG) revealed no pathological findings. He was observed in the ED. The results were in the normal range in his blood test and he has 0 mg/dl of blood ethanol. He experienced dizziness after 5 h and 30 min. The blood pressure was 60/30 mmHg. The heart rate was 34 beats/min. The simultaneous ECG showed junctional bradycardia. 0.5 mg atropine IV was given two times at intervals. Norepinephrine infusion was initiated after normal saline therapy. Forty-five minutes later, he did not have any clinically significant complaint. There are no pathological findings in his follow-up ECG and physical examination. He was discharged of his own accord 10 h after his ED admission. His initial mirtazapine level was 145 ng/ml when he came to the ED. Mirtazapine was known to have a safe cardiac profile both for regular dose and overdose. However, physicians should consider that it might induce a life-threatening bradyarrhythmia.

4 September 2025 in OSMANGAZİ JOURNAL OF MEDICINE
Verified
Journal Article
Closed access
RKRuşengül Koruk
Ruşengül Koruk
EOEngin Ozakin
Engin Ozakin
GTGökhan Temiz
Gökhan Temiz
NANurdan Acar
Nurdan Acar
MCMustafa Emin Canakci
Mustafa Emin Canakci
FKFiliz Baloğlu Kaya
Filiz Baloğlu Kaya
Contrast-induced nephropathy (CIN) is a serious complication following the administration of iodinated contrast media, contributing significantly to hospital-acquired acute kidney injury. Contrast-induced nephropathy is defined as either a ≥25% increase from baseline creatinine levels or an absolute increase >0.5 mg/dL, within 48–72 hours after contrast media administration. This study evaluated CIN incidence and associated risk factors in emergency department (ED) patients undergoing contrast-enhanced CT. A prospective observational study was conducted at a tertiary-care ED (June 2013–September 2014). Adults (≥18 years) undergoing CT were enrolled, excluding those with baseline creatinine >1.2 mg/dL, acute kidney injury, or hemodynamic instability. Of the contrast-enhanced CT group (n=171), 14 patients (8.1%) developed CIN, whereas in the non-contrast CT group (n=171), 12 patients (7.0%) developed nephropathy. Hospitalization (p=0.030), advanced age (p=0.026), anemia (p=0.045), leukocytosis (p=0.005), and reduced GFR (p=0.028) were identified as risk factors for contrast-induced nephropathy. In the non-contrast group, anemia (p=0.003), hospitalization (n=9; p=0.039), and leukocytosis (p=0.007) were identified as risk factors for nephropathy. No cases of nephropathy was observed in patients discharged from the ED in either group. Contrast media did not significantly increase nephropathy risk in ED patients with normal renal function. However, older age, anemia, and hospitalization identified high-risk subgroups. Prophylactic measures showed no clear benefit, possibly due to ED time constraints. Vigilance is recommended for elderly and hospitalized patients, with renal monitoring following contrast administration.

8 June 2025 in Emergency Medicine Journal
Verified
Journal Article
Closed access
PDF file
CKCaglar Kuas
Caglar Kuas
MCMustafa Emin Canakci
Mustafa Emin Canakci